These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 180877)

  • 21. [Treatment of myopathies and spinal muscular atrophies (author's transl)].
    Jerusalem F
    Schweiz Rundsch Med Prax; 1978 Jan; 67(4):118-22. PubMed ID: 341113
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thymus and myasthenia].
    de Crousaz G; Zoupanos G
    Rev Med Suisse Romande; 1973 Feb; 93(2):143-58. PubMed ID: 4704793
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thymectomy in the management of myasthenia].
    Balzereit F; Bay V; Otto H; Rittmeyer P; Sobirey C
    Z Neurol; 1972; 201(2):136-59. PubMed ID: 4112645
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):726-8. PubMed ID: 4325239
    [No Abstract]   [Full Text] [Related]  

  • 25. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 26. [The immunity phenomenon and neuromuscular diseases].
    Igata A
    Naika; 1968 Feb; 21(2):214-21. PubMed ID: 4301008
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of myasthenia gravis].
    Henze T
    Dtsch Med Wochenschr; 1986 Mar; 111(13):507-9. PubMed ID: 3956394
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
    Ghezzi M; Taiuti R; Marconi G
    Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W
    Med Welt; 1969 Nov; 48():2636-49. PubMed ID: 4318400
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of myasthenia gravis].
    Gajdos P
    Presse Med; 1989 Oct; 18(35):1732-4. PubMed ID: 2531386
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of myasthenia].
    Goulon M; Estournet B; Gajdos P
    Rev Prat; 1979 Jun; 29(35):2789-99. PubMed ID: 493836
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing patients who have myasthenia gravis.
    Johns TR
    West J Med; 1985 Jun; 142(6):810-3. PubMed ID: 4024633
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunosuppressive therapy of myasthenias].
    Mertens HG; Hertel G
    Med Welt; 1973 Jun; 24(23):955-63. PubMed ID: 4355431
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of myasthenia gravis.
    Pourmand R
    Indiana Med; 1987 Mar; 80(3):215-22. PubMed ID: 3571950
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myasthenia gravis].
    Takamori S
    Naika; 1970 Jun; 25(6):1322-7. PubMed ID: 4914457
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of myasthenia gravis.
    Drug Ther Bull; 1977 Apr; 15(8):29-32. PubMed ID: 872734
    [No Abstract]   [Full Text] [Related]  

  • 37. Current treatment of myasthenia gravis.
    Osterman PO
    Prog Brain Res; 1990; 84():151-61. PubMed ID: 2267293
    [No Abstract]   [Full Text] [Related]  

  • 38. Recurrence of nonneoplastic thymus after thymectomy for myasthenia gravis. Report of two cases.
    Joseph BS; Johns TR
    Neurology; 1973 Feb; 23(2):109-16. PubMed ID: 4347062
    [No Abstract]   [Full Text] [Related]  

  • 39. Adrenal steroid therapy in neurological disease. Part I.
    Eisen AA; Norris JW
    Can Med Assoc J; 1969 Jan; 100(1):27-30. PubMed ID: 4388115
    [No Abstract]   [Full Text] [Related]  

  • 40. Biology of myasthenia gravis.
    Lindstrom J; Dau P
    Annu Rev Pharmacol Toxicol; 1980; 20():337-62. PubMed ID: 6992700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.